Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Research Shows Promise of New Device to Detect Disease with Drop of Blood

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
An NJIT professor is overseeing the manufacture of a prototype lab-on-a-chip that would someday enable a physician to detect disease or virus from just one drop of liquid.

“Scalable nano-bioprobes with sub-cellular resolution for cell detection,” Biosensors and Bioelectronics, (Elsevier, Vol. 45), which will publish on July 15, 2013 but is available now online, describes how NJIT research professors Reginald Farrow and Alokik Kanwal, his former postdoctoral fellow, and their team have created a carbon nanotube-based device to noninvasively and quickly detect mobile single cells with the potential to maintain a high degree of spatial resolution.

“Using sensors, we created a device that will allow medical personnel to put a tiny drop of liquid on the active area of the device and measure the cells’ electrical properties,” said Farrow, the recipient of NJIT’s highest research honor, the NJIT Board of Overseers Excellence in Research Prize and Medal.  “Although we are not the only people by any means doing this kind of work, what we think is unique is how we measure the electrical properties or patterns of cells and how those properties differ between cell types.”

In the article, the NJIT researchers evaluated three different types of cells using three different electrical probes.  “It was an exploratory study and we don’t want to say that we have a signature,” Farrow added.  “What we do say here is that these cells differ based on electrical properties.  Establishing a signature, however, will take time, although we know that the distribution of electrical charges in a healthy cell changes markedly when it becomes sick.”

This research was originally funded by the military as a means to identify biological warfare agents.  However, Farrow believes that usage can go much further and potentially detect viruses, bacteria, even cancer.  The research may also someday even assess the health of good cells, such as brain neurons.  Since 2010, three U.S. patents, “Method of forming nanotube vertical field effect transistor,” #7,736,979 (2010); “Nanotube device and method of fabrication” #7,964,143 (2011); “Nanotube device and method of fabrication” #8,257,566 (2012) were awarded for this device.  In addition, more patents have been filed.

The device (shown in photo) utilizes standard complementary metal oxide semiconductor (CMOS) technologies for fabrication, allowing it to be easily scalable (down to a few nanometers).  Nanotubes are deposited using electrophoresis after fabrication in order to maintain CMOS compatibility.

The devices are spaced by six microns which is the same size or smaller than a single cell.  To demonstrate its capability to detect cells, the researchers performed impedance spectroscopy on mobile human embryonic kidney (HEK) cells, neurons from mice, and yeast cells.  Measurements were performed with and without cells and with and without nanotubes. Nanotubes were found to be crucial to successfully detect the presence of cells.

Carbon nanotubes are very strong, electrically conductive structures a single nanometer in diameter.  That’s one-billionth of a meter, or approximately ten hydrogen atoms in a row. Farrow’s breakthrough is a controlled method for firmly bonding one of these submicroscopic, crystalline electrical wires to a specific location on a substrate.  His method also introduces the option of simultaneously bonding an array of millions of nanotubes and efficiently manufacturing many devices at the same time.

Being able to position single carbon nanotubes that have specific properties opens the door to further significant advances.  Other possibilities include an artificial pancreas, three-dimensional electronic circuits and nanoscale fuel cells with unparalleled energy density.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!